181 related articles for article (PubMed ID: 12444818)
1. Nefazodone treatment of pathological gambling: a prospective open-label controlled trial.
Pallanti S; Baldini Rossi N; Sood E; Hollander E
J Clin Psychiatry; 2002 Nov; 63(11):1034-9. PubMed ID: 12444818
[TBL] [Abstract][Full Text] [Related]
2. Multicenter investigation of the opioid antagonist nalmefene in the treatment of pathological gambling.
Grant JE; Potenza MN; Hollander E; Cunningham-Williams R; Nurminen T; Smits G; Kallio A
Am J Psychiatry; 2006 Feb; 163(2):303-12. PubMed ID: 16449486
[TBL] [Abstract][Full Text] [Related]
3. A double-blind, placebo-controlled study of the opiate antagonist naltrexone in the treatment of pathological gambling urges.
Grant JE; Kim SW; Hartman BK
J Clin Psychiatry; 2008 May; 69(5):783-9. PubMed ID: 18384246
[TBL] [Abstract][Full Text] [Related]
4. Double-blind naltrexone and placebo comparison study in the treatment of pathological gambling.
Kim SW; Grant JE; Adson DE; Shin YC
Biol Psychiatry; 2001 Jun; 49(11):914-21. PubMed ID: 11377409
[TBL] [Abstract][Full Text] [Related]
5. Olanzapine in the treatment of pathological gambling: a negative randomized placebo-controlled trial.
McElroy SL; Nelson EB; Welge JA; Kaehler L; Keck PE
J Clin Psychiatry; 2008 Mar; 69(3):433-40. PubMed ID: 18251624
[TBL] [Abstract][Full Text] [Related]
6. Topiramate versus fluvoxamine in the treatment of pathological gambling: a randomized, blind-rater comparison study.
Dannon PN; Lowengrub K; Gonopolski Y; Musin E; Kotler M
Clin Neuropharmacol; 2005; 28(1):6-10. PubMed ID: 15711432
[TBL] [Abstract][Full Text] [Related]
7. Reliability and validity of the pathological gambling adaptation of the Yale-Brown Obsessive-Compulsive Scale (PG-YBOCS).
Pallanti S; DeCaria CM; Grant JE; Urpe M; Hollander E
J Gambl Stud; 2005; 21(4):431-43. PubMed ID: 16311876
[TBL] [Abstract][Full Text] [Related]
8. Lithium and valproate treatment of pathological gambling: a randomized single-blind study.
Pallanti S; Quercioli L; Sood E; Hollander E
J Clin Psychiatry; 2002 Jul; 63(7):559-64. PubMed ID: 12143910
[TBL] [Abstract][Full Text] [Related]
9. An open naltrexone treatment study in pathological gambling disorder.
Kim SW; Grant JE
Int Clin Psychopharmacol; 2001 Sep; 16(5):285-9. PubMed ID: 11552772
[TBL] [Abstract][Full Text] [Related]
10. An open-label trial of escitalopram in the treatment of pathological gambling.
Black DW; Shaw M; Forbush KT; Allen J
Clin Neuropharmacol; 2007; 30(4):206-12. PubMed ID: 17762317
[TBL] [Abstract][Full Text] [Related]
11. Short-term single-blind fluvoxamine treatment of pathological gambling.
Hollander E; DeCaria CM; Mari E; Wong CM; Mosovich S; Grossman R; Begaz T
Am J Psychiatry; 1998 Dec; 155(12):1781-3. PubMed ID: 9842795
[TBL] [Abstract][Full Text] [Related]
12. Does sustained-release lithium reduce impulsive gambling and affective instability versus placebo in pathological gamblers with bipolar spectrum disorders?
Hollander E; Pallanti S; Allen A; Sood E; Baldini Rossi N
Am J Psychiatry; 2005 Jan; 162(1):137-45. PubMed ID: 15625212
[TBL] [Abstract][Full Text] [Related]
13. Escitalopram treatment of pathological gambling with co-occurring anxiety: an open-label pilot study with double-blind discontinuation.
Grant JE; Potenza MN
Int Clin Psychopharmacol; 2006 Jul; 21(4):203-9. PubMed ID: 16687991
[TBL] [Abstract][Full Text] [Related]
14. An open-label study of citalopram in the treatment of pathological gambling.
Zimmerman M; Breen RB; Posternak MA
J Clin Psychiatry; 2002 Jan; 63(1):44-8. PubMed ID: 11838625
[TBL] [Abstract][Full Text] [Related]
15. Citalopram treatment of compulsive shopping: an open-label study.
Koran LM; Bullock KD; Hartston HJ; Elliott MA; D'Andrea V
J Clin Psychiatry; 2002 Aug; 63(8):704-8. PubMed ID: 12197451
[TBL] [Abstract][Full Text] [Related]
16. Comorbidity of impulse control disorders in pathological gamblers.
Grant JE; Kim SW
Acta Psychiatr Scand; 2003 Sep; 108(3):203-7. PubMed ID: 12890275
[TBL] [Abstract][Full Text] [Related]
17. Sertraline treatment of pathological gambling: a pilot study.
Saiz-Ruiz J; Blanco C; Ibáñez A; Masramon X; Gómez MM; Madrigal M; Díez T
J Clin Psychiatry; 2005 Jan; 66(1):28-33. PubMed ID: 15669885
[TBL] [Abstract][Full Text] [Related]
18. Extended release carbamazepine in the treatment of pathological gambling: an open-label study.
Black DW; Shaw MC; Allen J
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jul; 32(5):1191-4. PubMed ID: 18436362
[TBL] [Abstract][Full Text] [Related]
19. A double-blind comparison of nefazodone, imipramine, and placebo in major depression.
Fontaine R; Ontiveros A; Elie R; Kensler TT; Roberts DL; Kaplita S; Ecker JA; Faludi G
J Clin Psychiatry; 1994 Jun; 55(6):234-41. PubMed ID: 8071277
[TBL] [Abstract][Full Text] [Related]
20. A pilot study of impulsivity and compulsivity in pathological gambling.
Blanco C; Potenza MN; Kim SW; Ibáñez A; Zaninelli R; Saiz-Ruiz J; Grant JE
Psychiatry Res; 2009 May; 167(1-2):161-8. PubMed ID: 19339053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]